These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 8511144)

  • 41. [Use of the ISAGA method in detection of specific IgM, IgA, IgE antibodies in acquired and congenital toxoplasmosis].
    Paul M
    Wiad Parazytol; 1997; 43(1):39-51. PubMed ID: 9289926
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Management of congenital toxoplasmosis in France: current data].
    Garcia-Méric P; Franck J; Dumon H; Piarroux R
    Presse Med; 2010 May; 39(5):530-8. PubMed ID: 19926248
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Treatment of toxoplasmosis in the pregnant mother and newborn child.
    Stray-Pedersen B
    Scand J Infect Dis Suppl; 1992; 84():23-31. PubMed ID: 1290070
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Congenital infection with Toxoplasma gondii.
    Guerina NG
    Pediatr Ann; 1994 Mar; 23(3):138-42, 147-51. PubMed ID: 8015862
    [No Abstract]   [Full Text] [Related]  

  • 45. [The prevalence of Toxoplasma gondii infection among 2016 pregnant women and their children in the Institute of Mother and Child in Warsaw].
    Niemiec KT; Raczyński P; Markiewicz K; Leibschang J; Ceran A
    Wiad Parazytol; 2002; 48(3):293-9. PubMed ID: 16888975
    [TBL] [Abstract][Full Text] [Related]  

  • 46. IgM ELISA follow-up of spiramycin treatment for toxoplasmosis: should the drug be prescribed in India?
    Singh S
    J Assoc Physicians India; 1992 Feb; 40(2):140. PubMed ID: 1629136
    [No Abstract]   [Full Text] [Related]  

  • 47. Comparative value of polymerase chain reaction and conventional biological tests for the prenatal diagnosis of congenital toxoplasmosis.
    Dupouy-Camet J; Bougnoux ME; Lavareda de Souza S; Thulliez P; Dommergues M; Mandelbrot L; Ancelle T; Tourte-Schaefer C; Benarous R
    Ann Biol Clin (Paris); 1992; 50(5):315-9. PubMed ID: 1485688
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Risk factors for Toxoplasma gondii infection in mothers of infants with congenital toxoplasmosis: implications for prenatal management and screening.
    Levine EM
    Am J Obstet Gynecol; 2006 Feb; 194(2):589; author reply 590. PubMed ID: 16458668
    [No Abstract]   [Full Text] [Related]  

  • 49. [Toxoplasmosis].
    Maeda T
    Nihon Rinsho; 2003 Feb; 61 Suppl 2():603-7. PubMed ID: 12722288
    [No Abstract]   [Full Text] [Related]  

  • 50. Effectiveness of prenatal treatment for congenital toxoplasmosis: a meta-analysis of individual patients' data.
    ; Thiébaut R; Leproust S; Chêne G; Gilbert R
    Lancet; 2007 Jan; 369(9556):115-22. PubMed ID: 17223474
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Role of spiramycin in prevention of fetal toxoplasmosis.
    Avci ME; Arslan F; Çiftçi Ş; Ekiz A; Tüten A; Yildirim G; Madazli R
    J Matern Fetal Neonatal Med; 2016; 29(13):2073-6. PubMed ID: 26365472
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Congenital toxoplasmosis: An overview of the neurological and ocular manifestations.
    Khan K; Khan W
    Parasitol Int; 2018 Dec; 67(6):715-721. PubMed ID: 30041005
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Congenital toxoplasmosis: efficacy of maternal treatment with spiramycin alone.
    Vergani P; Ghidini A; Ceruti P; Strobelt N; Spelta A; Zapparoli B; Rescaldani R
    Am J Reprod Immunol; 1998 May; 39(5):335-40. PubMed ID: 9602252
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Early and longitudinal evaluations of treated infants and children and untreated historical patients with congenital toxoplasmosis: the Chicago Collaborative Treatment Trial.
    McAuley J; Boyer KM; Patel D; Mets M; Swisher C; Roizen N; Wolters C; Stein L; Stein M; Schey W
    Clin Infect Dis; 1994 Jan; 18(1):38-72. PubMed ID: 8054436
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Recommendations for the treatment of prenatal toxoplasma infection in the child. German Society of Pediatric Infectiology e.V. (DGPI), "Parasitology" Study Group].
    Döhring-Schwerdtfeger E; Leichsenring M; Liefke U; Padelt H; Sitzmann FC; Stehr K; Zimmermann PH
    Klin Padiatr; 1995; 207(1):38-41. PubMed ID: 7885018
    [No Abstract]   [Full Text] [Related]  

  • 56. [Congenital toxoplasmosis due to maternal reinfection during pregnancy].
    Valdès V; Legagneur H; Watrin V; Paris L; Hascoët JM
    Arch Pediatr; 2011 Jul; 18(7):761-3. PubMed ID: 21600743
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Neonatal serologic screening and early treatment for congenital Toxoplasma gondii infection. The New England Regional Toxoplasma Working Group.
    Guerina NG; Hsu HW; Meissner HC; Maguire JH; Lynfield R; Stechenberg B; Abroms I; Pasternack MS; Hoff R; Eaton RB
    N Engl J Med; 1994 Jun; 330(26):1858-63. PubMed ID: 7818637
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Toxoplasmosis in sick persons].
    Netrebko ID
    Lik Sprava; 2002; (8):90-3. PubMed ID: 12669554
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Diagnostic problems with congenital toxoplasmosis].
    Karczewski G; Gołab E
    Przegl Epidemiol; 2011; 65(3):451-4. PubMed ID: 22184947
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prenatal diagnosis and treatment of congenital Toxoplasma gondii infections: an experimental study in rhesus monkeys.
    Schoondermark-van de Ven EM; Melchers WJ; Galama JM; Meuwissen JH; Eskes TK
    Eur J Obstet Gynecol Reprod Biol; 1997 Aug; 74(2):183-8. PubMed ID: 9306115
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.